Allergy Therapeutics, a specialty pharmaceutical company, announced the appointment of Nick Wykeman to the board as finance director.Article continues below

READ MORE Allergy Therapeutics finance director Ian Postlethwaite resigns

Mr. Wykeman was most recently at Skyepharma PLC until August 2015 where he was the Group Financial Controller for six years.

Prior to that, he had also worked at Quest International (a part of ICI PLC) as the Group Financial Controller (Special Projects), following six years at Deloitte & Touche.

Mr. Wykeman has a BSc (Hons) in Economics and is a qualified accountant, being a member of the Institute of Chartered Accountants of England and Wales.

• Vectura Group appoints Anne Whitaker as director
• Hunting appoints two directors
• Taylor Wimpey appoints Chris Carney as finance director
• Tullow Oil appoints Dorothy Thompson as chair-designate
• PowerShares Global Funds Ireland appoints two to board